These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15114970)

  • 1. A cholesterol drug protects some people with diabetes.
    Heart Advis; 2003 Aug; 6(8):2. PubMed ID: 15114970
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins indispensable for people with diabetes.
    Health News; 2003 Aug; 9(8):6. PubMed ID: 12971317
    [No Abstract]   [Full Text] [Related]  

  • 3. Wider role seen for "remarkable" statins. Study suggests that benefits extend even to those with "normal" cholesterol levels.
    Heart Advis; 2002 Jan; 5(1):3. PubMed ID: 16145760
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
    Collins R
    Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 6. Lower cholesterol to lower heart risk.
    Clark WL
    Diabetes Self Manag; 2004; 21(3):19, 21-2, 25. PubMed ID: 15206362
    [No Abstract]   [Full Text] [Related]  

  • 7. Doubling Zocor dose fails to double its benefit.
    Health News; 2004 Nov; 10(11):11. PubMed ID: 15655859
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.
    Rosen JB; Jimenez JG; Pirags V; Vides H; Hanson ME; Massaad R; McPeters G; Brudi P; Triscari J
    Diab Vasc Dis Res; 2013 May; 10(3):277-86. PubMed ID: 23288881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I've read that, because I have type 2 diabetes, I should take a statin even though my cholesterol levels are normal. Is this true?
    Johns Hopkins Med Lett Health After 50; 2005 May; 17(3):8. PubMed ID: 15841555
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes: can we stop the time bomb?
    Fisher M
    Heart; 2003 May; 89 Suppl 2(Suppl 2):ii28-30; discussion ii35-7. PubMed ID: 12695433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for type 2 diabetes.
    Harv Womens Health Watch; 2004 Jul; 11(11):7. PubMed ID: 15273060
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE inhibitors reduce heart-related death in type 2 diabetics.
    Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126
    [No Abstract]   [Full Text] [Related]  

  • 13. Timing of simvastatin treatment: results are not what really matters.
    Ewald DP
    BMJ; 2004 Jan; 328(7432):167; author reply 168. PubMed ID: 14726361
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
    Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM
    Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin].
    Griebenow R
    Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286
    [No Abstract]   [Full Text] [Related]  

  • 16. Timing of simvastatin treatment: no matter the time of day, does UK policy reflect the evidence?
    Duerden MG; Allinson MD; Lockett J
    BMJ; 2004 Jan; 328(7432):168. PubMed ID: 14726363
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
    Hernborg A; Hjemdahl P; Håkansson J
    Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
    [No Abstract]   [Full Text] [Related]  

  • 18. Timing of simvastatin treatment: trial is not reported according to CONSORT guidelines.
    Calvert M; McManus R; MacLeod J
    BMJ; 2004 Jan; 328(7432):167-8; author reply 168. PubMed ID: 14726360
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol-lowering drug improves survival after heart transplant.
    FDA Consum; 2003; 37(1):7-8. PubMed ID: 12625296
    [No Abstract]   [Full Text] [Related]  

  • 20. Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?
    Sathyapalan T; Atkin SL; Kilpatrick ES
    Diabetes Obes Metab; 2010 Jun; 12(6):540-4. PubMed ID: 20518809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.